Screening for UBE3A gene mutations in a group of Angelman syndrome patients selected according to non-stringent clinical criteria
- PMID: 10647895
- DOI: 10.1007/s004399900197
Screening for UBE3A gene mutations in a group of Angelman syndrome patients selected according to non-stringent clinical criteria
Abstract
The Angelman syndrome (AS) is caused by genetic abnormalities affecting the maternal copy of chromosome region 15q12. Until recently, the molecular diagnosis of AS relied on the detection of either a deletion at 15q11-13, a paternal uniparental disomy (UPD) for chromosome 15 or imprinting mutations. A fourth class of genetic defects underlying AS was recently described and consists of mutations of the UBE3A gene. The vast majority of mutations reported so far are predicted to cause major disruptions at the protein level. It is unclear whether mutations with less drastic consequences for the gene product could lead to milder forms of AS. We report on our results obtained by screening 101 clinically diagnosed AS patients for mutations in the UBE3A gene. Non-stringent clinical criteria were purposely applied for inclusion of AS patients in this study. The mutation search was carried out by single-strand conformation polymorphism (SSCP), and SSCP/restriction fragment length polymorphism (RFLP) analyses and revealed five novel UBE3A gene mutations as well as three different polymorphisms. All five mutations were detected in patients with typical features of AS and are predicted to cause frameshifts in four cases and the substitution of a highly conserved residue in the fifth. The results we obtained add to the as yet limited number of reports concerning UBE3A gene mutations. Important aspects that emerge from the data available to date is that the four classes of genetic defects known to underlie AS do not appear to cover all cases. The genetic defect underlying approximately 10% of AS cases, including some familial cases, remains unknown.
Similar articles
-
Mutation analysis of UBE3A in Angelman syndrome patients.Am J Hum Genet. 1998 Jun;62(6):1353-60. doi: 10.1086/301877. Am J Hum Genet. 1998. PMID: 9585605 Free PMC article.
-
UBE3A/E6-AP mutations cause Angelman syndrome.Nat Genet. 1997 Jan;15(1):70-3. doi: 10.1038/ng0197-70. Nat Genet. 1997. PMID: 8988171
-
The spectrum of mutations in UBE3A causing Angelman syndrome.Hum Mol Genet. 1999 Jan;8(1):129-35. doi: 10.1093/hmg/8.1.129. Hum Mol Genet. 1999. PMID: 9887341
-
Angelman syndrome: a review of the clinical and genetic aspects.J Med Genet. 2003 Feb;40(2):87-95. doi: 10.1136/jmg.40.2.87. J Med Genet. 2003. PMID: 12566516 Free PMC article. Review.
-
Novel intragenic deletions within the UBE3A gene in two unrelated patients with Angelman syndrome: case report and review of the literature.BMC Med Genet. 2017 Nov 21;18(1):137. doi: 10.1186/s12881-017-0500-x. BMC Med Genet. 2017. PMID: 29162042 Free PMC article. Review.
Cited by
-
1031-1034delTAAC (Leu125Stop): a novel familial UBE3A mutation causing Angelman syndrome in two siblings showing distinct phenotypes.BMC Med Genet. 2012 Dec 20;13:124. doi: 10.1186/1471-2350-13-124. BMC Med Genet. 2012. PMID: 23256887 Free PMC article.
-
Identification of disease-linked hyperactivating mutations in UBE3A through large-scale functional variant analysis.Nat Commun. 2021 Nov 23;12(1):6809. doi: 10.1038/s41467-021-27156-0. Nat Commun. 2021. PMID: 34815418 Free PMC article.
-
Distinct phenotypes distinguish the molecular classes of Angelman syndrome.J Med Genet. 2001 Dec;38(12):834-45. doi: 10.1136/jmg.38.12.834. J Med Genet. 2001. PMID: 11748306 Free PMC article.
-
Loss of nuclear UBE3A activity is the predominant cause of Angelman syndrome in individuals carrying UBE3A missense mutations.Hum Mol Genet. 2021 Apr 30;30(6):430-442. doi: 10.1093/hmg/ddab050. Hum Mol Genet. 2021. PMID: 33607653 Free PMC article.
-
A novel UBE3A sequence variant identified in eight related individuals with neurodevelopmental delay, results in a phenotype which does not match the clinical criteria of Angelman syndrome.Mol Genet Genomic Med. 2020 Nov;8(11):e1481. doi: 10.1002/mgg3.1481. Epub 2020 Sep 5. Mol Genet Genomic Med. 2020. PMID: 32889787 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials